Animal study · mice

SLU-PP-332 reversed age-related kidney changes in old mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

In old mice, SLU-PP-332 acted like caloric restriction on the aging kidney, but this has not been shown in people.

Kind
Animal study
Studied in
Mice
Published
2023
Journal
Am J Pathol

What they tested

The team tested whether the estrogen-related receptors (ERRs), a family of receptors inside cells, help drive the mitochondrial problems and inflammation seen in aging kidneys, and whether switching them on with SLU-PP-332 could reverse those changes.

How the study was done

An animal study in which 21-month-old mice got SLU-PP-332, a compound that activates all ERR types, for 8 weeks. A separate group of old mice got C-176, a blocker of the STING pathway, for 3 weeks, and the team also compared aging human and mouse kidneys and mice kept on lifelong caloric restriction, meaning they ate fewer calories.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking SLU-PP-332? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

ERR levels were lower in aging kidneys from both people and mice, but stayed up in old mice on lifelong caloric restriction. In old mice, 8 weeks of SLU-PP-332 reversed the rise in albuminuria (the protein albumin leaking into urine), the loss of podocytes (filter cells in the kidney), mitochondrial dysfunction and inflammatory cytokines (immune signaling molecules), much like caloric restriction did. The team linked these effects to the cGAS-STING and STAT3 signaling pathways. In a separate group of old mice, 3 weeks of the STING blocker lowered inflammatory cytokines and the aging marker p21, and also restored PGC-1α, ERRα, mitochondrial complexes and MCAD, a fat-burning enzyme.

What it doesn’t show

This was work in old mice, so it is not a human result. The study looked at kidney markers over 8 weeks and did not test whether the changes held up longer or prevented kidney disease.

The paper

Wang et al. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney. Am J Pathol. 2023.

The compound

More studies on SLU-PP-332

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking SLU-PP-332? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo